Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1747-597X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia ; volume:17 ; number:1 ; day:28 ; month:3 ; year:2022 ; pages:1-6 ; date:12.2022
Substance abuse treatment, prevention, and policy ; 17, Heft 1 (28.3.2022), 1-6, 12.2022
- Creator
-
Butsashvili, Maia
Abzianidze, Tinatin
Kamkamidze, George
Gulbiani, Lasha
Gvinjilia, Lia
Kuchuloria, Tinatin
Tskhomelidze, Irina
Gogia, Maka
Tsereteli, Maia
Miollany, Veronique
Kikvidze, Tamar
Shadaker, Shaun
Nasrullah, Muazzam
Averhoff, Francisco
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13011-022-00438-6
- URN
-
urn:nbn:de:101:1-2022061723504168520517
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Butsashvili, Maia
- Abzianidze, Tinatin
- Kamkamidze, George
- Gulbiani, Lasha
- Gvinjilia, Lia
- Kuchuloria, Tinatin
- Tskhomelidze, Irina
- Gogia, Maka
- Tsereteli, Maia
- Miollany, Veronique
- Kikvidze, Tamar
- Shadaker, Shaun
- Nasrullah, Muazzam
- Averhoff, Francisco
- SpringerLink (Online service)
Other Objects (12)
Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016
Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
Prevalence of HCV among people who inject drugs in Brussels—a respondent-driven sampling survey
HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs
Gender Differences in HIV, HCV risk and Prevention Needs Among People who Inject drug in Vietnam
Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol
Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016
Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
Prevalence of HCV among people who inject drugs in Brussels—a respondent-driven sampling survey
HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs
Gender Differences in HIV, HCV risk and Prevention Needs Among People who Inject drug in Vietnam
Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol
Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016
Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients
Public Health Considerations among People who Inject Drugs with HIV/HCV Co-Infection: A Review
Prevalence of HCV among people who inject drugs in Brussels—a respondent-driven sampling survey
HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs
Gender Differences in HIV, HCV risk and Prevention Needs Among People who Inject drug in Vietnam